Celsion Corporation

(NASDAQ: CLSN) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

Contact Information

Website: www.celsion.com
Email: Sam@argotpartners.com
Main Phone: +1 609 896-9100
Address: 997 Lenox Drive
Address 2: Suite 100
State: NJ
City / Town: Lawrenceville
Country: US
Postal Code: 08648

Issuer Information

Exchange: NSC
CEO: Michael H. Tardugno
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A